Abstract Number: 2176 • 2012 ACR/ARHP Annual Meeting
Pulmonary Manifestations and Treatment of Primary Sjogren’s Syndrome-Associated Lung Involvement Patients: A Prospective Study
Background/Purpose: Pulmonary involvement is common in primary Sjögren’s syndrome (pSS). Clinicopathologic pulmonary manifestations associated with pSS have yet to be reviewed in a large series.…Abstract Number: 2177 • 2012 ACR/ARHP Annual Meeting
The Forced Oscillation Technique Is a Sensitive Method for Detection of Obstructive Airway Disease in Patients with Primary Sjögren’s Syndrome
Background/Purpose: To study signs of obstructive airway disease in patients with primary Sjögren’s syndrome (pSS) by the forced oscillation technique (FOT), a method that may…Abstract Number: 2178 • 2012 ACR/ARHP Annual Meeting
18-Fludeoxyglucose Positron Emission Tomography Is a Valuable Marker of Activity of Interstitial Lung Disease in Primary Sjogren’s Syndrome
Background/Purpose: Purpose: To assess the value of 18-Fludeoxyglucose Positron Emission Tomography (PET) in patients with primary Sjogren's Syndrome (pSS).Methods: All patients with confirmed pSS (AECG)…Abstract Number: 2179 • 2012 ACR/ARHP Annual Meeting
High Resolution CT Findings and Concomitant Nontuberculosis Mycobacterial Infection (NTM) in Patients with the Diagnosis of Primary Sjogren’s Syndrome Evaluated At a Respiratory Referral Center
Background/Purpose: Although lung disease can occur with primary Sjogren’s syndrome (pSS), far too little is known about the clinical phenotype or natural history of its lung…Abstract Number: 2180 • 2012 ACR/ARHP Annual Meeting
Coronary Flow Reserve and Asymmetric Dimethylarginine Levels: New Measurements for Identifying Subclinical Atherosclerosis in Patients with Primary Sjögren’s Syndrome
Background/Purpose: Clinical and biochemical data suggest that autoimmune diseases are associated with endothelial dysfunction and increased atherosclerosis. We have previously shown that asymmetric dimethylarginine (ADMA)…Abstract Number: 2181 • 2012 ACR/ARHP Annual Meeting
Concomitant Atheosclerosis and Impaired Bone Health in Patients with Primary Sjogren’s Syndrome
Background/Purpose: To determine the prevalence of subclinical atherosclerosis and impaired bone health in primary Sjogren’s syndrome (pSS) patients and to explore whether they associate with…Abstract Number: 2141 • 2012 ACR/ARHP Annual Meeting
Effects of Cigarette Smoking On EARLY Arthritis (CONAART)
Background/Purpose: According to recent reports the cigarette smoking persons have 2-4 times greater risk of developing rheumatoid arthritis (RA). The cigarette smoking is associated with…Abstract Number: 2142 • 2012 ACR/ARHP Annual Meeting
Magnetic Resonance Imaging-Proven Osteitis At Baseline Predicts the Early Rheumatoid Arthritis Patients Who Will Develop Rapid Radiographic Progression: MRI Is Beneficial to Find the Window of Opportunity in Early RA
Background/Purpose: Window of opportunity exists in the earlier phase of rheumatoid arthritis (RA), thus, early recognition of the RA patients who will develop rapid radiographic…Abstract Number: 2143 • 2012 ACR/ARHP Annual Meeting
Analysis of Factors Associated with the Health Assessment Questionnaire Score Change in Five Years
Background/Purpose: The Health Assessment Questionnaire (HAQ) score is thought to be a disease specific tool for the assessment of inflammatory joint disorders including rheumatoid arthritis…Abstract Number: 2144 • 2012 ACR/ARHP Annual Meeting
Early RA Patients Fulfilling the New 2010 ACR/EULAR Criteria, Display Better Clinical Responses to DMARD Therapy but Have Higher Radiographic Damage Progression Than Patients with Early RA Not Fulfilling the 2010 ACR/EULAR Criteria
Background/Purpose: New ACR/EULAR criteria for the classification of rheumatoid arthritis (RA) were recently proposed. The aim of this analysis was to examine the impact of…Abstract Number: 2145 • 2012 ACR/ARHP Annual Meeting
Age At Onset Determines Severity and choice of Treatment in Early Rheumatoid Arthritis
Background/Purpose: Mortality is increased in rheumatoid arthritis (RA). Contributing factors are disease activity/severity and comorbidity. A relationship between age at onset and pharmacological treatment has…Abstract Number: 2146 • 2012 ACR/ARHP Annual Meeting
Impact of Severity Index for Rheumatoid Arthritis On Healthcare Costs and Utilizations in Patients with Rheumatoid Arthritis
Background/Purpose: Examine the impact of a claims-based severity index for rheumatoid arthritis (RA) on healthcare costs and utilizations of RA patients using large U.S. claims…Abstract Number: 2147 • 2012 ACR/ARHP Annual Meeting
Risks to Visit Emergency Room in Patients with Rheumatoid Arthritis: A Two-Year Retrospective Study
Background/Purpose: Patients with rheumatoid arthritis (RA) suffer from both physical disabilities and medical comorbidities and tend to use emergency room for many reasons. However, the…Abstract Number: 2148 • 2012 ACR/ARHP Annual Meeting
Peer to Peer Mentoring for Individuals with Early Inflammatory Arthritis: Feasibility Pilot
Background/Purpose: The goal of this research is to examine the potential benefit of early peer support to improve the health and quality of life of…Abstract Number: 2149 • 2012 ACR/ARHP Annual Meeting
Atsttrin-â, an Engineered Protein Derived From Progranulin Growth Factor, Binds to TNF Receptors and Exhibits Potent Anti-Inflammatory Activity in Mice
Background/Purpose: Progranulin (PGRN) is a multifunctional growth factor. Recently, we reported that PGRN and its derived protein Atsttrin-α (referred to as “Atsttrin” in our previous…
ACR Meeting Abstracts